Metabolomics companies

  • Report ID: 515
  • Published Date: Aug 22, 2025
  • Report Format: PDF, PPT

Key Metabolomics Market Players:

    The metabolomics market features intense competition, where leaders in the U.S., such as Thermo Fisher, Agilent, and Bruker, dominate through advanced MS technology and AI analytics. Employment of cost-effective assets and formation of partnerships are the key strategies of these key players that solidify their leadership in this sector. On the other hand, pioneers in Europe are maintaining their competency via the development of specialized kits, while firms in Asia are more focused on cost-efficient high-throughput solutions.

    The cohort of top contenders includes:

    Company Name (Country)

    Industry Focus

    Market Share (2024)

    Thermo Fisher Scientific (U.S.)

    Leading provider of mass spectrometry & chromatography systems for metabolomics research.

    18.7%

    Agilent Technologies (U.S.)

    Specializes in LC-MS and NMR-based metabolomics solutions for clinical diagnostics.

    15.4%

    Bruker Corporation (U.S.)

    Advanced NMR and MALDI-TOF platforms for metabolomic profiling.

    12.3%

    Waters Corporation (U.S.)

    HPLC-MS systems for large-scale metabolomics studies in pharma & academia.

    10.3%

    SCIEX (U.S.)

    High-resolution mass spectrometers for biomarker discovery.

    7.6%

    Metabolon (U.S.)

    Proprietary metabolomics panels for disease research & drug development.

    xx%

    Biocrates Life Sciences (Austria)

    Targeted metabolomics kits for clinical and pharmaceutical applications.

    xx%

    LECO Corporation (U.S.)

    GC-TOF-MS systems for untargeted metabolomics.

    xx%

    Bio-Rad Laboratories (U.S.)

    Metabolomics reagents and software for data analysis.

    xx%

    PerkinElmer (U.S.)

    Integrated omics platforms for metabolomics & genomics.

    xx%

    Sciex (Danaher) (U.S.)

    QTRAP systems for quantitative metabolomics.

    xx%

    Phenomenex (U.S.)

    Chromatography columns optimized for metabolomic separations.

    xx%

    MetaboAnalyst (Canada)

    Cloud-based metabolomics data analysis software.

    xx%

    BGI Group (China)

    Large-scale metabolomics services for precision medicine.

    xx%

    ChromaCell Corporation (South Korea)

    Microfluidic-based metabolomics platforms for high-throughput screening.

    xx%

    Metabolomic Diagnostics (Ireland)

    Focus on pregnancy-related metabolomics biomarkers.

    xx%

    Microba Life Sciences (Australia)

    Gut microbiome metabolomics for personalized nutrition.

    xx%

    Xcelris Labs (India)

    Contract metabolomics services for pharmaceutical & agricultural research.

    xx%

    Shimadzu Corporation (Japan)

    GC-MS and LC-MS technologies for precision metabolomics.

    xx%

    Human Metabolome Technologies (Japan)

    Capillary electrophoresis-MS for small-molecule analysis.

    xx%

    JEOL Ltd. (Japan)

    Develops high-precision NMR and MS systems for metabolomic profiling.

    xx%

    Hitachi High-Tech (Japan)

    Focuses on high-speed LC-MS systems for real-time metabolomics in clinical diagnostics.

    xx%

    Sekisui Medical Co., Ltd. (Japan)

    Provides clinical metabolomics solutions, including diagnostic kits for metabolic disorders.

    xx%

    Below are the areas covered for each company in the metabolomics market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2026, the industry size of metabolomics is assessed at USD 4.7 billion.

The market size for the metabolomics market is projected to reach USD 15.04 billion by the end of 2035, expanding at a CAGR of 13.8% during the forecast period, i.e., between 2026-2035.

The major players in the market are Thermo Fisher Scientific, Agilent Technologies, Bruker Corporation, Waters Corporation, SCIEX, Metabolon, and others.

The instruments segment is expected to dominate the market with a 32.8% share by the end of 2035.

North America is the dominating region in the metabolomics market and is expected to hold the largest share of 40.5% by 2035.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos